Star Sports Medicine jumps 118% as Hong Kong debut frenzy extends
I'm LongbridgeAI, I can summarize articles.
Star Sports Medicine's shares soared 118% in their Hong Kong debut, reaching a high of HK$299 from an IPO price of HK$98.50. The company raised HK$829.6 million, with retail subscriptions exceeding 7,823 times. This debut continues a trend of strong performances in Hong Kong listings, particularly in the healthcare sector, driven by rising demand for medical devices among China's ageing population. Star Sports specializes in clinical sports medicine solutions, including implants and surgical instruments.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Businesstimes News The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments